Last reviewed · How we verify

NCT07418619: MEI

Minimum Effective Exercise Intensity in Sedentary Individuals

Recruiting now NA Last updated 18 February 2026
What this trial tests

NA trial testing Exercise in Sedentary Individuals Not Participating in Regular Exercise Training/Physical Activity in 100 participants. Currently enrolling.

Timeline
23 February 2026
Primary endpoint
20 December 2026
20 December 2026

Quick facts

Lead sponsorUKK Institute
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment100
Start date23 February 2026
Primary completion20 December 2026
Estimated completion20 December 2026
Sites2 locations across Finland

Drugs / interventions tested

Conditions studied

Sponsor

UKK Institute

Who can join

Adults 30 to 55, any sex, with Sedentary Individuals Not Participating in Regular Exercise Training/Physical Activity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this randomized controlled intervention study is to examine the minimum exercise intensity that has an effect on cardiorespiratory fitness and/or cardiometabolic risk factors in sedentary adults. In addition, the study seeks to examine which background factors explain individual differences in exercise responses.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other UKK Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07418619.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing